Bambusa Therapeutics is a startup based in Germany, most recent round Seed, 1 tracked investor.
Bambusa Therapeutics is a company founded in 2019 headquartered in Germany. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Bambusa Therapeutics is a German biotech company developing novel therapies for chronic inflammatory diseases. Their lead program targets a key pathway involved in various autoimmune and inflammatory conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.